We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11B
AUM Growth
+$6.3B
Cap. Flow
-$236M
Cap. Flow %
-2.13%
Top 10 Hldgs %
41.04%
Holding
1,273
New
73
Increased
578
Reduced
348
Closed
99

Sector Composition

Rank Sector Weight
1 Real Estate 62.34%
2 Technology 7.48%
3 Consumer Discretionary 3.58%
4 Healthcare 3.49%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INO icon
1026
Inovio Pharmaceuticals
INO
$85.6M
$10K ﹤0.01%
75
+28
+60% +$5.84K
OUT icon
1027
Outfront Media
OUT
$5.75B
$10K ﹤0.01%
+672
New +$10.1K
WNS
1028
DELISTED
WNS Holdings
WNS
$10K ﹤0.01%
150
AKCA
1029
DELISTED
Akcea Therapeutics Inc
AKCA
$10K ﹤0.01%
578
+48
+9% +$681
AUPH icon
1030
Aurinia Pharmaceuticals
AUPH
$1.95B
$9K ﹤0.01%
642
+46
+8% +$666
CLPR
1031
Clipper Realty
CLPR
$46.4M
$9K ﹤0.01%
1,568
+68
+5% +$461
EDIT icon
1032
Editas Medicine
EDIT
$399M
$9K ﹤0.01%
304
HCM icon
1033
HUTCHMED
HCM
$1.96B
$9K ﹤0.01%
278
+43
+18% +$1.34K
KURA icon
1034
Kura Oncology
KURA
$793M
$9K ﹤0.01%
288
LGND icon
1035
Ligand Pharmaceuticals
LGND
$5.77B
$9K ﹤0.01%
147
PACB icon
1036
Pacific Biosciences
PACB
$435M
$9K ﹤0.01%
864
QURE icon
1037
uniQure
QURE
$2.75B
$9K ﹤0.01%
246
VCYT icon
1038
Veracyte
VCYT
$4.45B
$9K ﹤0.01%
276
YMAB
1039
DELISTED
Y-mAbs Therapeutics
YMAB
$9K ﹤0.01%
224
ITCI
1040
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$9K ﹤0.01%
364
NSTG
1041
DELISTED
NanoString Technologies, Inc.
NSTG
$9K ﹤0.01%
202
AMRN
1042
Amarin Corp
AMRN
$297M
$8K ﹤0.01%
100
CYTK icon
1043
Cytokinetics
CYTK
$10.6B
$8K ﹤0.01%
363
FTI icon
1044
TechnipFMC
FTI
$28.6B
$8K ﹤0.01%
1,629
-24,005
-94% -$135K
IRWD icon
1045
Ironwood Pharmaceuticals
IRWD
$586M
$8K ﹤0.01%
885
MGNX icon
1046
MacroGenics
MGNX
$233M
$8K ﹤0.01%
310
SGMO
1047
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$8K ﹤0.01%
802
+148
+23% +$1.6K
ZG icon
1048
PUT
Zillow
ZG
$7.85B
$8K ﹤0.01%
1,688
-89
-5% -$6.93K
RVNC
1049
DELISTED
Revance Therapeutics, Inc.
RVNC
$8K ﹤0.01%
317
ICPT
1050
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8K ﹤0.01%
185

Similar funds

Daiwa Securities Group's Q3 2020 Portfolio in Review

As of Q3 2020, Daiwa Securities Group held 1,273 positions worth $11B, up 133% from $4.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group's Q3 2020 filing shows 73 new, 578 increased, 348 reduced and 99 closed positions. Its largest new stake was Global X Cloud Computing ETF: 2,004,400 shares worth $49M. The largest sale was Digital Realty Trust, an estimated $308M.

By sector, the portfolio is most concentrated in Real Estate at 62% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q3 2020 buy was Global X Cloud Computing ETF: 2,004,400 shares worth $49M.
  • Daiwa Securities Group added most to CyrusOne Inc Common Stock in Q3 2020, an estimated $268M increase.
  • Daiwa Securities Group's biggest Q3 2020 reduction was Digital Realty Trust, cutting an estimated $308M.
  • Daiwa Securities Group fully exited BWX Technologies in Q3 2020, selling an estimated $11.3M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11B portfolio in Q3 2020.
  • Daiwa Securities Group opened 73 new positions and closed 99 in Q3 2020.
  • Daiwa Securities Group's portfolio value rose 133% quarter-over-quarter to $11B.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.